LYMPHOPENIA IS AN INDEPENDENT RISK-FACTOR IN PATIENTS WITH LOW-RISK MDS ACCORDING TO THE IPSS-R

被引：0
|
作者：
Silzle, T. [1 ]
Schuler, E. [2 ]
Hildebrandt, B. [3 ]
Blum, S. [4 ]
Haas, R. [2 ]
Germing, U. [2 ]
机构：
[1] Cantonal Hosp St Gallen, Oncol Haematol, St Gallen, Switzerland
[2] Univ Hosp Dusseldorf, Dept Haematol Oncol & Clin Immunol, Dusseldorf, Germany
[3] Univ Hosp Dusseldorf, Inst Human Genet, Dusseldorf, Germany
[4] CHU Vaudois, Dept Oncol, Lausanne, Switzerland
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P664
引用
收藏
页码：263 / 263
页数：1
相关论文
共 50 条
  • [21] Transfusion Dependency Is Associated With Inferior Survival Even In Very Low and Low Risk IPSS-R Patients
    Hiwase, Devendra K.
    Kutyna, Monika M.
    Chhetri, Rakchha
    Howell, Stuart
    Harrison, Peter B.
    Nath, Shriram V.
    Nath, Lakshmi S.
    Wickham, Nicholas
    Szabo, Ferenc
    Hui, Chi-Hung
    Ross, David
    Gray, James
    Melo, Junia V.
    Bardy, Peter
    To, L. Bik
    BLOOD, 2013, 122 (21)
  • [22] IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
    Yang, Yi-Tsung
    Hou, Hsin-An
    Liu, Chieh-Yu
    Lin, Chien-Chin
    Chou, Wen-Chien
    Lee, Fen-Yu
    Liu, Ming-Chih
    Liu, Chia-Wen
    Tang, Jih-Luh
    Yao, Ming
    Li, Chi-Cheng
    Kuo, Yuan-Yeh
    Huang, Shang-Yi
    Ko, Bor-Sheng
    Chen, Chien-Yuan
    Hsu, Szu-Chun
    Lin, Chien-Ting
    Wu, Shang-Ju
    Tsay, Woei
    Chen, Yao-Chang
    Tien, Hwei-Fang
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (09) : E142 - E149
  • [23] Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R
    Moon, Joon Ho
    Sohn, Sang Kyun
    Ahn, Jae Sook
    Kim, Yeo-Kyeoung
    Kim, Hyeoung Joon
    Song, Moo-Kon
    Shin, Ho-Jin
    Chung, Joo-Seop
    Song, Ik Chan
    Jo, Deog-Yeon
    Lim, Sung Nam
    Lee, Ho Sup
    Kim, Yang Soo
    Bae, Sung Hwa
    BLOOD, 2013, 122 (21)
  • [24] Is the IPSS-R Useful for Patients with MDS Receiving Disease-Modifying Treatment?
    Blum, Sabine
    Gattermann, Norbert
    Martins, Filipe
    Nachtkamp, Kathrin
    Kuendgen, Andrea
    Kobbe, Guido
    Germing, Ulrich
    BLOOD, 2016, 128 (22)
  • [25] A Retrospective Validation Study Comparing the IPSS-M and IPSS-R Risk Stratification Scores in Primary and Secondary Myelodysplastic Syndrome (MDS)
    Sabile, Jean M. G.
    Kaempf, Andy
    Tomic, Kaitlyn
    Manu, Gurusidda
    Swords, Ronan T.
    Migdady, Yazan
    BLOOD, 2022, 140 : 4088 - 4089
  • [26] INCORPORATION OF COHESIN MUTATIONAL DATA INTO CURRENT IPSS-R CLASSIFICATION REFINES THE PROGNOSTIC STRATIFICATION OF VERY LOW/LOW-RISK MYELODYSPLASTIC SYNDROMES
    Martin Izquierdo, M.
    Diez-Campelo, M.
    Sanchez Del Real, J.
    Hernandez Sanchez, A.
    Hernandez Sanchez, J. M.
    Janusz, K.
    Lopez, F.
    Tormo, M.
    Megido, M.
    Olivier, C.
    Madinaveitia-Ochoa, A.
    Davila, J.
    Sierra, M.
    Vargas, M.
    Santos Minguez, S.
    Miguel Garcia, C.
    Benito, R.
    Hernandez Rivas, J. M.
    Ramos, F.
    Abaigar, M.
    LEUKEMIA RESEARCH, 2021, 108 : S15 - S16
  • [27] Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M
    Rigodanza, Luca
    Consagra, Angela
    Alessandro, Sanna
    Cassari, Margherita
    Tofacchi, Elena
    de Pourcq, Sven Jiulien Maria
    Mattiuz, Giorgio
    Amato, Cristina
    Raddi, Marco Gabriele
    Santini, Valeria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S367 - S368
  • [28] AN INTERNATIONAL REVISED FORECAST INDEX (IPSS-R) OF 3.5 POINTS STRATIFIES PATIENTS WITH MYELODYSPLASIC SYNDROME (MDS) IN 2 RISK GROUPS
    Montoro, Maria Julia
    Ortega, Margarita
    Villacampa, Guillermo
    Bernal, Teresa
    Pomares, Helena
    Mora, Elvira
    Molero, Antonieta
    Colado, Enrique
    Tormo, Mar
    Diaz, Marina
    Merchan, Brayan
    Jerez, Andres
    Rivero, Eugenia
    Lis, Maria Jose
    Corcel, Paula
    Bargay, Joan
    Ramos, Fernando
    Xicoy, Blanca
    Diez-Campelo, Maria
    Valcarcel, David
    HAEMATOLOGICA, 2020, 105 : 72 - 73
  • [29] Clonal Evolution in Patients with Low-Risk MDS
    Mazzeo, P.
    Ganster, C.
    Brzuszkiewicz, E. B.
    Rittscher, K.
    Kamper, M.
    Goetze, K.
    Mueller-Thomas, C.
    Balaian, E.
    Sockel, K.
    Platzbecker, U.
    Shirneshan, K.
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 36 - 36
  • [30] Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)
    Gangat, Naseema
    Patnaik, Mrinal M.
    Begna, Kebede
    Kourelius, Taxiarchis
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Hodnefield, Janice M.
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2012, 120 (21)
12345